ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$49.22
−2.17%Forward multiples
Based on analyst estimates
- P/E forward
- 30.65x
- P/E 2026E
- 45.41x
- P/E 2027E
- 23.68x
- P/E 2028E
- 15.71x
- P/S forward
- 6.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- 105.85x
- PEG TTM
- 0.43x
- Price / book
- 30.20x
- Price / sales
- 13.32x
- Price / cash flow
- 92.95x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 13.34x
- EV / EBITDA
- 70.63x
- EV / EBIT
- 86.39x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026